Rocket One Overview
- Year Founded
-
2017
- Status
-
Public
- Employees
-
3
- Stock Symbol
-
RKTO
- Investments
-
3
- Share Price
-
$0.30
- (As of Friday Closing)
Rocket One General Information
Description
Rocket One Inc is focused on developing and commercializing infrastructure for the orbital economy, including next-generation nanomagnetic AI chip technology designed for radiation-tolerant, energy-constrained environments such as low-Earth orbit, deep-space platforms, and defense systems. The company also intends to pursue opportunities related to nano-launch systems and nanosatellite deployment. In addition, its biotechnology operations, conducted through a wholly owned subsidiary, include development programs such as HT-001, HT-KIT, HT-ALZ, and a GDNF-based metabolic program.
Contact Information
Website
www.rocketone.spaceCorporate Office
- 720 Monroe Street
- Suite E514
- Hoboken, NJ 07030
- United States
Corporate Office
- 720 Monroe Street
- Suite E514
- Hoboken, NJ 07030
- United States
Rocket One Timeline
Rocket One Stock Performance
As of 20-Nov-2026, Rocket One’s stock price is $0.30. Its current market cap is $7.39M with 24.9M shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $0.30 | $0.28 | $0.26 - $2.45 | $7.39M | 24.9M | 342K | -$0.61 |
Rocket One Financials Summary
As of 30-Sep-2026, Rocket One has a trailing 12-month revenue of $35.00.
|
In Thousands, USD |
TTM 30-Sep-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | 9,890 | 7,525 | (2,824) | (5,594) |
| Revenue | 0 | 0 | 0 | 0 |
| EBITDA | (11,894) | (12,469) | (8,188) | (8,106) |
| Net Income | (11,894) | (12,469) | (8,188) | (8,106) |
| Total Assets | 8,660 | 7,603 | 7,713 | 10,243 |
| Total Debt | 0 | 6 | 31 | 55 |
Rocket One Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Rocket One Comparisons
Industry
Financing
Details
Rocket One Competitors (2)
One of Rocket One’s 2 competitors is Lily AI, a Venture Capital-Backed company based in Mountain View, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Lily AI | Venture Capital-Backed | Mountain View, CA | ||||
| Pfizer | Corporation | New York, NY |
Rocket One Patents
Rocket One Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026043989-A1 | Topical aprepitant formulation | Pending | 21-Aug-2024 | ||
| WO-2025151396-A1 | Use of aprepitant for relieving side effects associated with the administration of weight loss medications | Inactive | 08-Jan-2024 | ||
| EP-4297868-A1 | Use of aprepitant for treating alzheimer's disease | Pending | 23-Feb-2021 | ||
| EP-4297868-A4 | Use of aprepitant for treating alzheimer's disease | Pending | 23-Feb-2021 | ||
| US-12144815-B2 | Use of aprepitant for treating alzheimer's disease | Active | 23-Feb-2021 | A61K31/5377 |
Rocket One Signals
Rocket One Investments & Acquisitions (3)
Rocket One’s most recent deal was a Merger/Acquisition with Tracer Drone Technologies. The deal was made on 18-Sep-2026.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Tracer Drone Technologies | 18-Sep-2026 | Merger/Acquisition | Aerospace and Defense | ||
| Obesity Treatment Development (Hoth Therapeutics / Silo Pharma) | 25-Jun-2025 | Joint Venture | Drug Discovery | ||
| HaloVax | 23-Mar-2020 | Joint Venture | Biotechnology |
Rocket One ESG
Risk Overview
Risk Rating
Updated November, 04, 2026
42.42 | Severe Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 13,593
Rank
Percentile
Pharmaceuticals
Industry
of 852
Rank
Percentile
Pharmaceuticals
Subindustry
of 354
Rank
Percentile
Rocket One Exits (1)
Rocket One’s most recent exit was on 23-Mar-2020 from HaloVax. The exit was categorized as with 2 buyers.
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| HaloVax | 23-Mar-2020 | Completed |
|
Rocket One FAQs
-
When was Rocket One founded?
Rocket One was founded in 2017.
-
Where is Rocket One headquartered?
Rocket One is headquartered in Hoboken, NJ.
-
What is the size of Rocket One?
Rocket One has 3 total employees.
-
What industry is Rocket One in?
Rocket One’s primary industry is Application Specific Semiconductors.
-
Is Rocket One a private or public company?
Rocket One is a Public company.
-
What is Rocket One’s stock symbol?
The ticker symbol for Rocket One is RKTO.
-
What is the current stock price of Rocket One?
As of 20-Nov-2026 the stock price of Rocket One is $0.30.
-
What is the current market cap of Rocket One?
The current market capitalization of Rocket One is $7.39M.
-
What is Rocket One’s current revenue?
The trailing twelve month revenue for Rocket One is $35.00.
-
Who are Rocket One’s competitors?
-
What is Rocket One’s annual earnings per share (EPS)?
Rocket One’s EPS for 12 months was -$0.61.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process